Full Press Release Details
NEW BRUNSWICK, N.J. , April 27, 2020 /PRNewswire/ -- Johnson & Johnson ("the Company") (NYSE: JNJ ) today announced that U.S. District Judge Freda L. Wolfson , chief judge of the District of New Jersey , who is presiding over the federal multidistrict litigation (MDL) involving claims that Johnson's Baby Powder causes ovarian cancer, decided that certain plaintiff expert witnesses did not present scientifically sound evidence to support aspects of their opinions and therefore cannot present these theories before a jury.
SPECIFICS OF DAUBERT RULING
Among other findings, the opinion states that:
ADDITIONAL INFORMATION
All verdicts against the Company that have been through the appeals process have been overturned. In addition, the most recent published cohort study , published in the Journal of the American Medical Association , pooled a number of high-level epidemiological studies and found no statistically significant increased risk of ovarian cancer with talc use.
Johnson & Johnson understands the talc litigation has caused confusion and concern about the safety of Johnson's Baby Powder and is committed to ensuring the facts about talc are understood. Johnson's Baby Powder has been a trusted product for more than 100 years, and decades of independent scientific evaluations have repeatedly confirmed that Johnson's Baby Powder does not cause cancer. Not a single professional organization or regulator has concluded that there is scientific evidence supporting the plaintiff claim of causation between talc and ovarian cancer.
We invite you to learn more about the science and safety of our talc at: https://www.factsabouttalc.com .
About Johnson & Johnson At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That's why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world's largest and most broadly-based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity. Learn more at www.jnj.com . Follow us at @jnjglobalhealth.
Cautions Concerning Forward-Looking Statements
SOURCE Johnson & Johnson